Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, CPBIO Holding Co's Enterprise Value is HK$2,598 Mil.
CPBIO Holding Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0 Mil. Therefore, CPBIO Holding Co's EV-to-FCF for today is .
The historical rank and industry rank for CPBIO Holding Co's EV-to-FCF or its related term are showing as below:
HKSE:03839'
s EV-to-FCF Range Over the Past 10 Years
Min: 0 Med: 0 Max: 12.01
Current: 11.91
During the past 12 years, the highest EV-to-FCF of CPBIO Holding Co was 12.01. The lowest was 0.00. And the median was 0.00.
HKSE:03839's EV-to-FCF is ranked better than 72.33% of 571
companies
in the Drug Manufacturers industry
Industry Median: 21.2
vs HKSE:03839: 11.91
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
CPBIO Holding Co (HKSE:03839) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
CPBIO Holding Co's PE Ratio (TTM) for today is calculated as:
CPBIO Holding Co's share price for today is HK$9.10.
CPBIO Holding Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.921.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
CPBIO Holding Co EV-to-FCF Related Terms
CPBIO Holding Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for CPBIO Holding Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, CPBIO Holding Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CPBIO Holding Co EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CPBIO Holding Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where CPBIO Holding Co's EV-to-FCF falls into.
CPBIO Holding Co's current Enterprise Value is HK$2,598 Mil.
CPBIO Holding Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Is CPBIO Holding Co (HKSE:03839) Overvalued in 2026?
Based on GuruFocus' analysis, CPBIO Holding Co stock appears to be overvalued.
The current stock price of HK$9.10 is trading 108.7% above its estimated GF Value™ of HK$4.36.
GuruFocus considers CPBIO Holding Co to be Significantly Overvalued.
Key valuation signals for HKSE:03839:
EV-to-FCF:
GF Value™: HK$4.36 vs. price of HK$9.10 (108.7% above fair value)
No single metric tells the full story. See the HKSE:03839 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chia Tai Enterprises International Ltd is engaged in the manufacture and sale of animal health products and chlortetracycline (CTC). The group has two reportable segments: Biotech Business and Investment Business. The Biotech Business segment is involved in the manufacture and/or sale of animal health products and chlortetracycline. The Investment Business segment is engaged in the trading of machinery and the manufacture and sale of automotive parts through the group's joint ventures and associates. It generates the majority of its revenue from the Biotech Business segment. Its geographical segments are Mainland China, which generates key revenue, Asia Pacific (excluding mainland China), the Americas, Europe, and Others.
71GF Score
Get the complete analysis for HKSE:03839
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:03839 has been successfully added to your 
